Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5600
-0.0050 (-0.88%)
Aug 7, 2026, 4:13 PM AEST
Aroa Biosurgery Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aroa Biosurgery stock has a consensus rating of "Strong Buy" and an average price target of $1.09. The average 1-year stock price forecast is 94.64% higher than the current stock price, while the lowest is $0.80 (+42.86%) and the highest is $1.38 (+146.43%).
Price Target: $1.09 (+94.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aroa Biosurgery stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $1.09 | Buy | Maintains | $1.09 | +94.64% | Jul 12, 2026 |
| Morgans | Morgans | Buy Maintains $0.77 → $0.79 | Buy | Maintains | $0.77 → $0.79 | +41.07% | May 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.16 → $1.35 | Buy | Maintains | $1.16 → $1.35 | +141.07% | May 3, 2026 |
Financial Forecast
Revenue This Year
120.66M
from 103.85M
Increased by 16.18%
Revenue Next Year
138.62M
from 120.66M
Increased by 14.89%
EPS This Year
0.02
from 0.02
Decreased by -10.66%
EPS Next Year
0.04
from 0.02
Increased by 135.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.